Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to human papillomavirus (HPV) infection. This study explores MSMs’ perceptions of HPV and HPV vaccination prior to the introduction of this programme. Design: Focus groups and one-to-one interviews with self-identified MSM were conducted between November 2014 and March 2015 in Brighton, UK. Methods: Participants were recruited from community-based lesbian–gay–bisexual–transgender (LGBT) venues and organizations. Discussions were recorded, transcribed verbatim, and analysed using framework analysis. Results: Thirty-three men took part (median age 25 years, IQR: 21–27), most of whom (n = 25) did not know about HPV, anal cancer (31), or HPV va...
Background/introduction Men who have sex with men (MSM) are at risk of HPV-associated genital warts ...
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. ...
ObjectiveAn HPV vaccine has been approved for men aged 9 to 26 in the US for the prevention of genit...
Objectives Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to human...
Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to huma...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Human Papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital warts among MSM. Co...
The human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Gay, bis...
Background: Men who have sex with men (MSM) are selected for Human Papillomavirus (HPV) vaccination ...
Background Female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. g...
Objectives: Men-who-have-sex-with-men (MSM) are at greater risk for HPV-associated cancers. Since 20...
The human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Gay, bis...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background/introduction Men who have sex with men (MSM) are at risk of HPV-associated genital warts ...
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. ...
ObjectiveAn HPV vaccine has been approved for men aged 9 to 26 in the US for the prevention of genit...
Objectives Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to human...
Objectives: Men who have sex with men (MSM) are at risk of genital warts and anal cancer due to huma...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Background Targeted human papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital...
Human Papillomavirus (HPV) vaccine could prevent HPV-related cancers and genital warts among MSM. Co...
The human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Gay, bis...
Background: Men who have sex with men (MSM) are selected for Human Papillomavirus (HPV) vaccination ...
Background Female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. g...
Objectives: Men-who-have-sex-with-men (MSM) are at greater risk for HPV-associated cancers. Since 20...
The human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. Gay, bis...
Background: Men who have sex with men (MSM) are recommended the Human Papillomavirus (HPV) vaccinati...
Background/introduction Men who have sex with men (MSM) are at risk of HPV-associated genital warts ...
Background: female-only HPV vaccination will fail to protect MSM against HPV and its sequelae i.e. ...
ObjectiveAn HPV vaccine has been approved for men aged 9 to 26 in the US for the prevention of genit...